1Maslovsky I, Uriev L, Lugassy G. The heterogeneity of Castleman disease: report of five cases and review of the literature. Am J Med Sci,2000,320: 292-295. 被引量：1
2Parez N, Bader-Meunier B, Roy CC, et al. Paediatric Castleman disease: report of seven cases and review of the literature. Eur J Pediatr,1999,158:631-637. 被引量：1
3Dhingra H, Sondhi D, Fleischman J, et al. Castlman's disease and superior vena cava thrombi : a rare presentation and a review of the literature. M Sinai J Med, 2001,68:410-416. 被引量：1
4Bowne WB, Lewis JJ, Filippa DA, et al. The management of uniceatric and multicentric Castleman' s disease: a report of 16 cases and a review of the literature. Cancer, 1999,85: 706-717. 被引量：1
5Larroche C, Cacottb P, Soulier J, et al. Castleman' s disease and lymphoma:report of eight cases in HIV-negative patients and literature review. Am J Hematol, 2002,69:119-126. 被引量：1
6Dupin N, Diss TL, Kellam P, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood, 2000,95 : 1406-1412. 被引量：1
7Lamy T, Loughran TP Jr. Clinical features of large granular lymphocyte leukemia[J]. Semin Hematol, 2003,40:185. 被引量：1
8Lima M, Almeida J, Montero AG, et al. Clinicobiological, immunophenotypic, and characteristics of monoclonal CD56 -/+ dim chronic natural killer cell large granular lymphocytosis[ J]. Am J Pathol, 2004,165:1117. 被引量：1
9Rosenward A, Wright G, Chan WC, et al. The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma[J]. N Engl J Med, 2002,346:1937. 被引量：1
